Macular edema after rhegmatogenous retinal detachment: can we treat it effectively?

REFERENCES

• Merad M, Verite F, Baudin F, et al. Cystoid Macular Edema after Rhegmatogenous Retinal Detachment Repair with Pars Plana Vitrectomy: Rate, Risk Factors, and Outcomes. J Clin Med. 2022 Aug 21;11(16). 10.3390/jcm11164914 4914
   PubMed Web of Science ®Google Scholar
• Bonnet M. Prognosis of cystoid macular edema after retinal detachment repair. Graefes Arch Clin Exp Ophthalmol. 1986;224(1):13–17. doi: 10.1007/BF02144125
   PubMed Web of Science ®Google Scholar
• Wang JC, Ryan EH, Ryan C, et al. Factors Associated with the Use of 360-Degree Laser Retinopexy during Primary Vitrectomy with or without Scleral Buckle for Rhegmatogenous Retinal Detachment and Impact on Surgical Outcomes (Pro Study Report Number 4). Retina. 2020 Nov;40(11):2070–2076.
   Google Scholar
• Shah YS, Abidi M, Ahmed I, et al. Risk Factors Associated with Cystoid Macular Edema among Patients Undergoing Primary Repair of Rhegmatogenous Retinal Detachment. Ophthalmol Retina. 2024 May;8(5):456–464.
   PubMedGoogle Scholar
• Gu R, Zhou M, Jiang C, et al. Elevated concentration of cytokines in aqueous in post-vitrectomy eyes. Clin Exp Ophthalmol. 2016 Mar;44(2):128–134. 10.1111/ceo.12638
   PubMed Web of Science ®Google Scholar
• Gebler M, Pfeiffer S, Callizo J, et al. Incidence and risk factors for macular oedema after primary rhegmatogenous retinal detachment surgery: a prospective single-centre study. Acta Ophthalmol. 2022 May;100(3):295–301. 10.1111/aos.14940
   PubMed Web of Science ®Google Scholar
• Lai TT, Huang JS, Yeh PT Incidence and risk factors for cystoid macular edema following scleral buckling. Eye (Lond). 2017 Apr;31(4):566–571.10.1038/eye.2016.264
   PubMed Web of Science ®Google Scholar
• Kon CH, Occleston NL, Aylward GW, et al. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest Ophthalmol Vis Sci. 1999 Mar;40(3):705–712.
   PubMed Web of Science ®Google Scholar
• Bonnet M. Macular changes and fluorescein angiographic findings after repair of proliferative vitreoretinopathy. Retina. 1994;14(5):404–410. doi: 10.1097/00006982-199414050-00003
   PubMed Web of Science ®Google Scholar
• Stopa M, Kociecki J. Anatomy and function of the macula in patients after retinectomy for retinal detachment complicated by proliferative vitreoretinopathy. Eur J Ophthalmol. 2011 Jul-Aug;21(4):468–72.
   PubMed Web of Science ®Google Scholar
• Kontou EP, Karakosta C, Kounas K, et al. Macular Edema Following Silicone Oil Tamponade for Retinal Detachment: A Literature Review. Cureus. 2023 Dec;15(12):e51233.10.7759/cureus.51233
   PubMed Web of Science ®Google Scholar
• Alam MR, Arcinue CA, Mendoza NB, et al. Recalcitrant Cystoid Macular Edema after Pars Plana Vitrectomy. Retina. 2016 Jul;36(7):1244–1251.10.1097/IAE.0000000000000892
   PubMed Web of Science ®Google Scholar
• Souissi S, Allou V, Trucchi L, et al. Macular oedema secondary to rhegmatogenous retinal detachment repair: risk factors for resistance to first-line therapy and long-term response to dexamethasone intravitreal implant. Eye (Lond). 2024 Apr;38(6):1155–1161.10.1038/s41433-023-02852-x
   PubMed Web of Science ®Google Scholar
• Flach AJ, Dolan BJ, Irvine AR Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. Am J Ophthalmol. 1987 Apr 15;103(4):479–486. 10.1016/S0002-9394(14)74268-0
   PubMed Web of Science ®Google Scholar
• Sivaprasad S, Bunce C, Crosby-Nwaobi R Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database Syst Rev. 2012 Feb 15(2):CD004239. 10.1002/14651858.CD004239.pub3
   Google Scholar
• Yasuda K, Motohashi R, Kotake O, et al. Comparative Effects of Topical Diclofenac and Betamethasone on Inflammation After Vitrectomy and Cataract Surgery in Various Vitreoretinal Diseases. J Ocul Pharmacol Ther. 2016 Dec;32(10):677–684. 10.1089/jop.2016.0099
   PubMed Web of Science ®Google Scholar
• Chin HS, Park TS, Moon YS, et al. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes. Retina. 2005 Jul-Aug;25(5):556–560.10.1097/00006982-200507000-00002
   PubMed Web of Science ®Google Scholar
• Pole C, Chehaibou I, Govetto A, et al. Macular edema after rhegmatogenous retinal detachment repair: risk factors, OCT analysis, and treatment responses. Int J Retina Vitreous. 2021 Jan 25;7(1):9. 10.1186/s40942-020-00254-9
   PubMedGoogle Scholar
• Zheng A, Chin EK, Almeida DR, et al. Combined Vitrectomy and Intravitreal Dexamethasone (Ozurdex) Sustained-Release Implant. Retina. 2016 Nov;36(11):2087–2092.
   PubMed Web of Science ®Google Scholar
• Chatziralli I, Theodossiadis G, Dimitriou E, et al. Macular Edema after Successful Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment: Factors Affecting Edema Development and Considerations for Treatment. Ocul Immunol Inflamm. 2021 Jan 2;29(1):187–192. 10.1080/09273948.2019.1652330
   PubMed Web of Science ®Google Scholar
• Thanos A, Todorich B, Yonekawa Y, et al. Dexamethasone intravitreal implant for the treatment of recalcitrant macular edema after rhegmatogenous retinal detachment repair. Retina. 2018 Jun;38(6):1084–1090. doi: 10.1097/IAE.0000000000001720
   PubMed Web of Science ®Google Scholar
• Bellocq D, Pierre-Kahn V, Matonti F, et al. Effectiveness and safety of dexamethasone implants for postsurgical macular oedema including Irvine-Gass syndrome: the EPISODIC-2 study. Br J Ophthalmol. 2017 Mar;101(3):333–341.
   PubMed Web of Science ®Google Scholar
• Bellocq D, Korobelnik JF, Burillon C, et al. Effectiveness and safety of dexamethasone implants for post-surgical macular oedema including Irvine-Gass syndrome: the EPISODIC study. Br J Ophthalmol. 2015 Jul;99(7):979–983.10.1136/bjophthalmol-2014-306159
   PubMed Web of Science ®Google Scholar
• Banerjee PJ, Quartilho A, Bunce C, et al. Slow-release dexamethasone in proliferative vitreoretinopathy: a prospective, randomized controlled clinical trial. Ophthalmology. 2017 Jun;124(6):757–767. doi: 10.1016/j.ophtha.2017.01.021
   PubMed Web of Science ®Google Scholar
• Khurana RN, Porco TC Efficacy and Safety of Dexamethasone Intravitreal Implant for Persistent Uveitic Cystoid Macular Edema. Retina. 2015 Aug;35(8):1640–1646.10.1097/IAE.0000000000000515
   PubMed Web of Science ®Google Scholar
• Alfaqawi F, Sarmad A, Ayesh K, et al. Intravitreal Fluocinolone Acetonide (ILUVIEN) Implant for the Treatment of Refractory Cystoid Macular Oedema After Retinal Detachment Repair. Turk J Ophthalmol. 2018 Jun;48(3):155–157. 10.4274/tjo.34966
   PubMedGoogle Scholar